ADRD |
Alzheimer’s disease and related dementias |
AUC |
area under the curve |
BBB |
blood–brain barrier |
BH |
Benjamini–Hochberg |
CAM |
Confusion Assessment Method |
CCL2 |
C-C motif chemokine 2 |
CCL28 |
C-C motif chemokine 28 |
CD38 |
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 |
CFL1 |
cofilin-1 |
CHI3L1/YKL-40 |
chitinase 3-like protein-1 |
CRP |
C-reactive protein |
CSF |
cerebrospinal fluid |
CTSD |
cathepsin L2 |
CTSV |
cathepsin D |
CXCL6 |
C-X-C motif chemokine 6 |
CXCL11 |
C-X-C motif chemokine 11 |
DSI |
Delirium Symptom Interview |
FC |
Fold-change |
GO |
Gene Ontology |
HiPOR |
Healthier Postoperative Recovery study |
HCA |
hierarchical cluster analysis |
IGF |
insulin-like growth factor |
IGFBP2 |
insulin-like growth factor binding protein-2 |
Ins |
insulin |
IPA |
Ingenuity Pathway Analysis |
MMP-14 |
matrix metalloproteinase-14 |
MMSE |
Mini-Mental State Examination |
MSN |
moesin |
NAD |
nicotinamide adenine dinucleotide |
NAMPT |
nicotinamide phosphoribosyltransferase |
NGF |
β-nerve growth factor |
PARK7 |
Parkinson disease protein 7 |
PCA |
principal components analysis |
PD |
Parkinson’s disease |
POD |
postoperative day |
QC |
quality control |
ROC |
receiver operating characteristic curve |
STRING |
Search Tool for the Retrieval of Interacting Genes/Proteins |
SSD |
Subsyndromal delirium |
SVM |
support vector machines |
THPO |
thrombopoietin |
UPGMA |
Unweighted Pair Group Method with Arithmetic-mean |